2021
DOI: 10.1158/1078-0432.ccr-21-0998
|View full text |Cite
|
Sign up to set email alerts
|

Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic Cancer

Abstract: Statement of translational relevanceFOLFIRINOX has demonstrated promising clinical results for patients with pancreatic ductal adenocarcinoma (PDAC). While the immunogenicity of certain chemotherapeutics has been demonstrated, little is known about the impact of neoadjuvant FOLFIRINOX chemotherapy on the immune system in PDAC patients.Here we performed immune phenotype analysis by CyTOF in peripheral blood of untreated patients and FOLFIRINOX-treated patients in the neoadjuvant setting. Distinct immune profile… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
25
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(27 citation statements)
references
References 52 publications
0
25
2
Order By: Relevance
“…This may explain our results, in which activation of CD8 + T cells, as well as the high abundance of memory T cells, significantly prolongs the OS time of CC patients. Surprisingly, the results showed that high Treg infiltration was significantly associated with good prognosis of patients, which was quite opposite to the phenomenon widely reported thus far ( Banerjee et al, 2021 ; Dahlhoff et al, 2021 ; Peng et al, 2021 ). In previous reports, little literature has mentioned that Treg can participate in the immune process as a protective factor.…”
Section: Discussioncontrasting
confidence: 98%
“…This may explain our results, in which activation of CD8 + T cells, as well as the high abundance of memory T cells, significantly prolongs the OS time of CC patients. Surprisingly, the results showed that high Treg infiltration was significantly associated with good prognosis of patients, which was quite opposite to the phenomenon widely reported thus far ( Banerjee et al, 2021 ; Dahlhoff et al, 2021 ; Peng et al, 2021 ). In previous reports, little literature has mentioned that Treg can participate in the immune process as a protective factor.…”
Section: Discussioncontrasting
confidence: 98%
“…In contrast, chemotherapy can also induce immunosuppressive effects, including the increase in tumor-promoting MDSCs [ 41 , 42 , 43 ]. In addition, it has been reported that neoadjuvant chemotherapy results in an increased frequency of PDAC-infiltrating CD4 + and CD8 + T cells, while the density of Tregs and MDSCs decreases [ 44 , 45 , 46 , 47 ]. Following these findings, we explored the influence of neoadjuvant chemotherapy on the level of PDAC-associated DCs.…”
Section: Resultsmentioning
confidence: 99%
“…In human PDAC patients, higher plasma concentrations of CXCL9 and CXCL10 in patients also correlate with improved overall survival (Qian et al, 2019). Abundance of CXCR3-expressing T cell infiltration has been shown to correlate with better responses to FOLFIRINOX (Peng et al, 2021). In mouse colorectal models, CXCR3 signaling was also shown to be required for responsivity to PD1 blockade (Chow et al, 2019).…”
Section: Discussionmentioning
confidence: 99%